NIH-funded research NIH-funded research

How human cellular protein complexes form inside cells

Official title: Molecular mechanisms underlying the assembly of the human proteasome and endogenous protein complexes

Funded at Sanford Burnham Prebys Medical Discovery Institute · NIH-11382072 · Data updated 2026-11-12

A research project uses advanced imaging and gene editing to study how human protein machines assemble inside cells, with a focus on the proteasome and related complexes.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSanford Burnham Prebys Medical Discovery Institute
NIH-funded
Lab location1 site (La Jolla, United States)
Project startAugust 1, 2022
Project endJuly 31, 2027
Funding year2026
Award (this year)$487,500
NIH project number5R35GM147487-05
Project IDNIH-11382072 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are patients or populations with cancers where proteasome function and complex assembly are relevant to disease biology, and who have available tissue or blood samples for correlative studies.

Less likely to help

Patients not affected by cancers or unrelated conditions may not directly benefit.

What this research studies

This project aims to develop methods to tag and purify endogenous human proteins using CRISPR/Cas genome editing so we can study protein machines under natural cellular conditions. By applying cryo-EM, scientists will visualize assembly pathways of important complexes like the proteasome in their native context, which could reveal how they function in health and disease. The work involves refining sample prep, studying constitutive and cell-type specific complexes, and exploring how cell state affects membrane protein assemblies in cancers. The research is designed to translate structural insights into better understanding of cancer biology and potential therapeutic targets.

Why it matters

Potential benefit: If successful, it could lead to deeper understanding of how cancer-related protein complexes assemble, potentially guiding new treatments.

How similar studies have gone: Previous work shows that endogenous tagging and cryo-EM can reveal native complex structures, with growing success in understanding assembly pathways.

Where this research is happening

  • Sanford Burnham Prebys Medical Discovery Institute
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Zhao, Jianhua — Sanford Burnham Prebys Medical Discovery Institute
  • Study coordinator: Zhao, Jianhua

Related research

Other NIH-funded projects on the same topics.

  • Aging and liver cancer: new ways to prevent and fight hepatocellular carcinoma

    This research explores how aging promotes liver cancer and tests new preventive approaches that could help people at higher risk due to age.

    NIH research Sanford Burnham Prebys Medical Discovery Institute · La Jolla, United States · NIH-11602178

  • EPHA2 signaling and breast cancer spread tied to the body’s stiffness

    This grant explores how the EPHA2 receptor helps breast cancer cells respond to the stiffness of their surroundings and whether activating EPHA2’s normal signaling can block cancer invasion.

    NIH research Sanford Burnham Prebys Medical Discovery Institute · La Jolla, United States · NIH-11473221

  • Molecule-focused study on soluble TREM2 in Alzheimer's disease

    A study to understand how soluble TREM2 in the brain and spinal fluid may influence Alzheimer's disease in people with the condition or at risk for it.

    NIH research Sanford Burnham Prebys Medical Discovery Institute · La Jolla, United States · NIH-11463281

  • How NRF2 and FBP1 control liver metabolism

    This work looks at whether changes in two liver proteins, NRF2 and FBP1, help explain low blood sugar and fat buildup in the liver for people with metabolic liver problems or rare FBP1 deficiency.

    NIH research Sanford Burnham Prebys Medical Discovery Institute · La Jolla, United States · NIH-11457999

  • How mitochondrial and immune signals drive inflammation linked to Alzheimer's

    This project looks at how damaged mitochondria and immune signaling cause inflammation that may contribute to Alzheimer's disease.

    NIH research Sanford Burnham Prebys Medical Discovery Institute · La Jolla, United States · NIH-11457998

  • Nup210’s role in leukemia and its potential as a target

    A doctor-scientist team is studying how a protein called Nup210 helps a type of blood cancer (AML) grow, with the goal of finding new ways to predict outcomes and treat the disease.

    NIH research Sanford Burnham Prebys Medical Discovery Institute · La Jolla, United States · NIH-11451105

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.